Your browser doesn't support javascript.
loading
Comment on «Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis» / Réplica a: «El análisis de supervivencia no es un buen método para evaluar la seguridad o la efectividad de los tratamientos sistémicos en psoriasis»
Reek, JMPA van den; Kievit, W; Jong, EMGJ de.
Affiliation
  • Reek, JMPA van den; Radboud University Medical Center. Department of Dermatology. Nijmegen. The Netherlands
  • Kievit, W; Radboud Institute of Health Sciences. Department of Health Evidence. Nijmegen. The Netherlands
  • Jong, EMGJ de; Radboud University Medical Center. Department of Dermatology. Nijmegen. The Netherlands
Actas dermo-sifiliogr. (Ed. impr.) ; 108(7): 695-696, sept. 2017.
Article in English | IBECS | ID: ibc-166937
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
No disponible
Subject(s)
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Psoriasis / Pharmaceutical Preparations / Drug Monitoring Limits: Humans Language: English Journal: Actas dermo-sifiliogr. (Ed. impr.) Year: 2017 Document type: Article Institution/Affiliation country: Radboud Institute of Health Sciences/The Netherlands / Radboud University Medical Center/The Netherlands
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Psoriasis / Pharmaceutical Preparations / Drug Monitoring Limits: Humans Language: English Journal: Actas dermo-sifiliogr. (Ed. impr.) Year: 2017 Document type: Article Institution/Affiliation country: Radboud Institute of Health Sciences/The Netherlands / Radboud University Medical Center/The Netherlands